Critical reagent characterization and re-evaluation to ensure long-term stability: two case studies

Teresa M Caiazzo1, Christopher M Shea1, Alison P Joyce1

  • 1Pfizer Inc., BioMedicine Design, One Burtt Road, Andover, MA 01810, USA.

Bioanalysis
|April 22, 2021
PubMed
Summary

Optimizing reagent conjugation and purification conditions, particularly pH, significantly reduces aggregate formation in ligand-binding assays. This proactive characterization ensures long-term reagent stability and assay performance.